Gale E. Smith, Ph.D., Chief Scientist, promoted to Senior Vice President
Troy Morgan, J.D., appointed Chief Compliance Officer
Greg Covino to step down as Chief Financial Officer, remain with company as executive adviser
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the promotion of Gale E. Smith, Ph.D., to Senior Vice President, Discovery and Pre-Clinical Research and Chief Scientist, and the appointment of Troy Morgan as Senior Vice President, Chief Compliance Officer. The company also announced that Greg Covino will be stepping down as Chief Financial Officer (CFO) and will take on a new role as executive adviser to the company.
Recognized as a pioneer in vaccine research, Dr. Smith is the sen…